The pharmacy industry is arming itself with new programs to combat theft
Q&A: PBM Legislation “Highly Likely” to Pass This Year
Following the Federal Trade Commission’s interim report on PBMs, legislators are galvanized to make change happen.
How Pharmacy Advocacy is Heating Up at the Federal Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Ribociclib Plus Aromatase Inhibitor Approved as Adjuvant Therapy for HR+/HER2- Early Breast Cancer
This approval offers an additional treatment option for a disease that can commonly return.
Breaking Down Return Solutions’ Rx Returns Process with Jeremy Cundiff
Jeremy Cundiff, PharmD, co-owner of Professional Pharmacy Group, joined Drug Topics to discuss Return Solutions and the company’s Rx Returns process.
FDA Approves Benralizumab for Eosinophilic Granulomatosis with Polyangiitis
The approval was based on data from the phase 3 MANDARA trial, where the therapy met the primary endpoint of proportion of patients in remission at weeks 36 and 48.
GSK Announces Positive Topline Data for Co-Administration of RSV, Shingles Vaccines
A co-administration option for both vaccinations can increase the likelihood of older adults completing the vaccination series and improve health outcomes for the patient population.
